Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

Cyclophosphamide 21 Cytarabine 13 venetoclax 12 Vincristine 12 Dexamethasone 12 Methotrexate 10 Etoposide 9 Doxorubicin 9 prednylidene 8 deltacortene 8 Prednisone 8 merphos 7 dexamethasone acetate 7 dexamethasone 21-phosphate 7 auricularum 7 Calcium Dobesilate 7 fludarabine phosphate 6 pegaspargase 5 fludarabine 5 azathiopurine 5 Stem Cell Transplantation 5 Specimen Handling 5 Sirolimus 5 Mercaptopurine 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Azacitidine 5 Whole-Body Irradiation 4 Rituximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡